Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in their interests in the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of insider trading activity rather than a financial performance report.
Material Changes
The material change disclosed is the acquisition of ordinary shares by connected persons under the Company's ShareReward Plan on May 12, 2014:
- Mr P C Thomson: Acquired 2 Ordinary Shares under the personal contribution element of the Plan.
- Mrs K Thomson: Acquired 2 Ordinary Shares under the matching element of the Plan (Company contribution).
- Transaction Price: 1612.8925 pence per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the total number of shares held by Mr P C Thomson and Mrs K Thomson following this transaction.
- Confirm the terms of the ShareReward Plan regarding personal contributions and company matching.
- Note that this filing does not contain financial performance data for the period.